Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine
Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as
Add-on Therapy in Symptomatic Subjects with Pulmonary Arterial Hypertension (PAH).